Surgical Therapies for Pulmonary Arterial Hypertension

Clinics in Chest Medicine

Volumn 28, Issue 1, 2007, Pages 187-202

  Sager, Jeffrey S ^a   Ahya, Vivek N ^a  

^a Pulmonary   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PROSTACYCLIN; SILDENAFIL;

ANASTOMOSIS DEHISCENCE; ARTERIAL OXYGEN SATURATION; ARTERY DISEASE; ASPERGILLOSIS; BLALOCK HANLON OPERATION; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; CYTOMEGALOVIRUS; GASTROESOPHAGEAL REFLUX; GRAFT DYSFUNCTION; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; HEART LUNG TRANSPLANTATION; HEART OUTPUT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FAILURE; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG TRANSPLANTATION; NONHUMAN; OPERATION DURATION; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATIENT REFERRAL; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; RECIPIENT; REVIEW; SAFETY; STOMACH PARESIS; SURGICAL TECHNIQUE; SURVIVAL; SYNDROME CREST; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ECHOCARDIOGRAPHY, DOPPLER; GRAFT REJECTION; HEART SEPTUM; HEART-LUNG TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE;

EID: 33847360064     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2006.11.003     Document Type: Review

References (142)

1. Hoeper M.M., Mayer E., Simonneau G., et al. Chronic thromboembolic pulmonary hypertension. Circulation 113 16 (2006) 2011-2020
2. D'Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 5 (1991) 343-349
3. Galie N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 20 (2005) 2148-2157
4. Rubin L.J., Badesch D.B., Barst R.J., et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346 12 (2002) 896-903
5. Simonneau G., Barst R.J., Galie N., et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 165 6 (2002) 800-804
6. Barst R.J., Rubin L.J., McGoon M.D., et al. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 121 6 (1994) 409-415
7. Rothman A., Sklansky M.S., Lucas V.W., et al. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol 84 6 (1999) 682-686
8. Rozkovec A., Montanes P., and Oakley C.M. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 55 5 (1986) 449-458
9. Glanville A.R., Burke C.M., Theodore J., et al. Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation. Chest 91 5 (1987) 675-681
10. Hopkins W.E., Ochoa L.L., Richardson G.W., et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 15 1 Pt 1 (1996) 100-105
11. Hopkins W.E. The remarkable right ventricle of patients with Eisenmenger syndrome. Coron Artery Dis 16 1 (2005) 19-25
12. Hopkins W.E., and Waggoner A.D. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. Am J Cardiol 89 1 (2002) 34-38
13. Austen W.G., Morrow A.G., and Berry W.B. Experimental studies of the surgical treatment of primary pulmonary hypertension. J Thorac Cardiovasc Surg 48 (1964) 448-455
14. Kawut S.M., Horn E.M., Berekashvili K.K., et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 95 2 (2005) 199-203
15. Collins T.J., Moore J.W., and Kirby W.C. Atrial septostomy for pulmonary hypertension. Am Heart J 116 3 (1988) 873-874
16. Fulwani M., Nabar A., Iyer R., et al. Palliative blade-balloon atrial septostomy in primary pulmonary hypertension. Indian Heart J 49 2 (1997) 185-186
17. Hausknecht M.J., Sims R.E., Nihill M.R., et al. Successful palliation of primary pulmonary hypertension by atrial septostomy. Am J Cardiol 65 15 (1990) 1045-1046
18. Kerstein D., Levy P.S., Hsu D.T., et al. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation 91 7 (1995) 2028-2035
19. Nihill M.R., O'Laughlin M.P., and Mullins C.E. Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease. Cathet Cardiovasc Diagn 24 3 (1991) 166-172
20. Rich S., Dodin E., and McLaughlin V.V. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol 80 3 (1997) 369-371
21. Sandoval J., Gaspar J., Pulido T., et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 32 2 (1998) 297-304
22. Thanopoulos B.D., Georgakopoulos D., Tsaousis G.S., et al. Percutaneous balloon dilatation of the atrial septum: immediate and midterm results. Heart 76 6 (1996) 502-506
23. Unger P., Stoupel E., Vachiery J.L., et al. Atrial septostomy under transesophageal guidance in a patient with primary pulmonary hypertension and absent right superior vena cava. Intensive Care Med 22 12 (1996) 1410-1411
24. Micheletti A., Hislop A.A., Lammers A., et al. Role of atrial septostomy in the treatment of children with pulmonary arterial hypertension. Heart 92 7 (2006) 969-972
25. Doyle R.L., McCrory D., Channick R.N., et al. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 1 Suppl (2004) 63S-71S
26. Chau E.M., Fan K.Y., and Chow W.H. Combined atrial septostomy and oral sildenafil for severe right ventricular failure due to primary pulmonary hypertension. Hong Kong Med J 10 4 (2004) 281-284
27. Laine J.F., Slama M., Petitpretz P., et al. Danger of vasodilator therapy for pulmonary hypertension in patent foramen ovale. Chest 89 6 (1986) 894-895
28. Barst R.J. Role of atrial septostomy in the treatment of pulmonary vascular disease. Thorax 55 2 (2000) 95-96
29. Reichenberger F., Pepke-Zaba J., McNeil K., et al. Atrial septostomy in the treatment of severe pulmonary arterial hypertension. Thorax 58 9 (2003) 797-800
30. Ali Khan M.A., Bricker J.T., Mullins C.E., et al. Blade atrial septostomy: experience with the first 50 procedures. Cathet Cardiovasc Diagn 23 4 (1991) 257-262
31. Allcock R.J., O'Sullivan J.J., and Corris P.A. Atrial septostomy for pulmonary arterial hypertension. Heart 89 11 (2003) 1344-1347
32. Rothman A., Beltran D., Kriett J.M., et al. Graded balloon dilation atrial septostomy as a bridge to lung transplantation in pulmonary hypertension. Am Heart J 125 6 (1993) 1763-1766
33. Bunch T.J., Asirvatham S.J., Friedman P.A., et al. Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol 16 11 (2005) 1172-1179
34. Sherman W., Lee P., Hartley A., et al. Transatrial septal catheterization using a new radiofrequency probe. Catheter Cardiovasc Interv 66 1 (2005) 14-17
35. Sakata Y., and Feldman T. Transcatheter creation of atrial septal perforation using a radiofrequency transseptal system: novel approach as an alternative to transseptal needle puncture. Catheter Cardiovasc Interv 64 3 (2005) 327-332
36. Roelke M., Smith A.J., and Palacios I.F. The technique and safety of transseptal left heart catheterization: the Massachusetts General Hospital experience with 1,279 procedures. Cathet Cardiovasc Diagn 32 4 (1994) 332-339
37. Kipel G., Arnon R., and Ritter S.B. Transesophageal echocardiographic guidance of balloon atrial septostomy. J Am Soc Echocardiogr 4 6 (1991) 631-635
38. Bidoggia H., Maciel J.P., and Alvarez J.A. Transseptal left heart catheterization: usefulness of the intracavitary electrocardiogram in the localization of the fossa ovalis. Cathet Cardiovasc Diagn 24 3 (1991) 221-225
39. Oztunc F., Saltik I.L., Batmaz G., et al. Balloon atrial septostomy under echocardiographic guidance. Case report. Turk J Pediatr 40 3 (1998) 437-440
40. Moscucci M., Dairywala I.T., Chetcuti S., et al. Balloon atrial septostomy in end-stage pulmonary hypertension guided by a novel intracardiac echocardiographic transducer. Catheter Cardiovasc Interv 52 4 (2001) 530-534
41. Cafri C., de la Guardia B., Barasch E., et al. Transseptal puncture guided by intracardiac echocardiography during percutaneous transvenous mitral commissurotomy in patients with distorted anatomy of the fossa ovalis. Catheter Cardiovasc Interv 50 4 (2000) 463-467
42. Zanchetta M., Rigatelli G., Pedon L., et al. Role of intracardiac echocardiography in atrial septal abnormalities. J Interv Cardiol 16 1 (2003) 63-77
43. Zanchetta M., Rigatelli G., Pedon L., et al. Intracardiac echocardiography: gross anatomy and magnetic resonance correlations and validations. Int J Cardiovasc Imaging 21 4 (2005) 391-401
44. Zanchetta M., Rigatelli G., Pedon L., et al. Transcatheter atrial septal defect closure assisted by intracardiac echocardiography: 3-year follow-up. J Interv Cardiol 17 2 (2004) 95-98
45. Boccalandro F., Baptista E., Muench A., et al. Comparison of intracardiac echocardiography versus transesophageal echocardiography guidance for percutaneous transcatheter closure of atrial septal defect. Am J Cardiol 93 4 (2004) 437-440
46. Kothari S.S., Yusuf A., Juneja R., et al. Graded balloon atrial septostomy in severe pulmonary hypertension. Indian Heart J 54 2 (2002) 164-169
47. Sandoval J., Rothman A., and Pulido T. Atrial septostomy for pulmonary hypertension. Clin Chest Med 22 3 (2001) 547-560
48. Taichman D.B., Shin J., Hud L., et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res 6 (2005) 92
49. Arcasoy S.M., and Kotloff R.M. Lung transplantation. N Engl J Med 340 14 (1999) 1081-1091
50. Trulock E.P., Edwards L.B., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report-2006. J Heart Lung Transplant 25 8 (2006) 880-892
51. Trulock E.P., Edwards L.B., Taylor D.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant 24 8 (2005) 956-967
52. McLaughlin V.V., Shillington A., and Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 106 12 (2002) 1477-1482
53. Shapiro S.M., Oudiz R.J., Cao T., et al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol 30 2 (1997) 343-349
54. Kuhn K.P., Byrne D.W., Arbogast P.G., et al. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am J Respir Crit Care Med 167 4 (2003) 580-586
55. Conte J.V., Gaine S.P., Orens J.B., et al. The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation. J Heart Lung Transplant 17 7 (1998) 679-685
56. Sitbon O., Humbert M., Nunes H., et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 40 4 (2002) 780-788
57. Minai O.A., and Arroliga A.C. Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan. South Med J 99 8 (2006) 880-883
58. McLaughlin V.V., Oudiz R.J., Frost A., et al. Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension. Am J Respir Crit Care Med 174 11 (2006) 1257-1263
59. Lunze K., Gilbert N., Mebus S., et al. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension. Eur J Clin Invest 36 Suppl 3 (2006) 32-38
60. Orens J.B., Estenne M., Arcasoy S., et al. International guidelines for the selection of lung transplant candidates: 2006 update-a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 25 7 (2006) 745-755
61. Barst R.J., Langleben D., Badesch D., et al. Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol 47 10 (2006) 2049-2056
62. Olschewski H., Simonneau G., Galie N., et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 347 5 (2002) 322-329
63. Hoeper M.M., Galie N., Simonneau G., et al. New treatments for pulmonary arterial hypertension. Am J Respir Crit Care Med 165 9 (2002) 1209-1216
64. Egan T.M., Murray S., Bustami R.T., et al. Development of the new lung allocation system in the United States. Am J Transplant 6 5 Pt 2 (2006) 1212-1227
65. Daliento L., Somerville J., Presbitero P., et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 19 12 (1998) 1845-1855
66. Oya H., Nagaya N., Uematsu M., et al. Poor prognosis and related factors in adults with Eisenmenger syndrome. Am Heart J 143 4 (2002) 739-744
67. Waddell T.K., Bennett L., Kennedy R., et al. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant 21 7 (2002) 731-737
68. Kasimir M.T., Seebacher G., Jaksch P., et al. Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation. Eur J Cardiothorac Surg 26 4 (2004) 776-781
69. Maurer J.R., Frost A.E., Estenne M., et al. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant 17 7 (1998) 703-709
70. Levine S.M. A survey of clinical practice of lung transplantation in North America. Chest 125 4 (2004) 1224-1238
71. Hadjiliadis D., Duane Davis R., Steele M.P., et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transpl 17 4 (2003) 363-368
72. Franke U.F., Wahlers T., Wittwer T., et al. Heart-lung transplantation is the method of choice in the treatment of patients with end-stage pulmonary hypertension. Transplant Proc 34 6 (2002) 2181-2182
73. Ueno T., Smith J.A., Snell G.I., et al. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger's syndrome. Ann Thorac Surg 69 2 (2000) 381-387
74. Chapelier A., Vouhe P., Macchiarini P., et al. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 106 2 (1993) 299-307
75. Whyte R.I., Robbins R.C., Altinger J., et al. Heart-lung transplantation for primary pulmonary hypertension. Ann Thorac Surg 67 4 (1999) 937-941 [discussion: 941-2]
76. Bando K., Armitage J.M., Paradis I.L., et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 108 6 (1994) 1056-1065
77. Klepetko W., Mayer E., Sandoval J., et al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 43 12 Suppl S (2004) 73S-80S
78. Gammie J.S., Keenan R.J., Pham S.M., et al. Single-versus double-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 115 2 (1998) 397-402 [discussion: 402-3]
79. Moulton M.J., Creswell L.L., Ungacta F.F., et al. Magnetic resonance imaging provides evidence for remodeling of the right ventricle after single-lung transplantation for pulmonary hypertension. Circulation 94 9 Suppl (1996) II312-II319
80. Pasque M.K., Trulock E.P., Cooper J.D., et al. Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients. Circulation 92 8 (1995) 2252-2258
81. Mendeloff E.N., Meyers B.F., Sundt T.M., et al. Lung transplantation for pulmonary vascular disease. Ann Thorac Surg 73 1 (2002) 209-217 [discussion: 217-9]
82. Sager J.S., Kotloff R.M., Ahya V.N., et al. Association of clinical risk factors with functional status following lung transplantation. Am J Transplant 6 9 (2006) 2191-2201
83. Orens J.B., Becker F.S., Lynch III J.P., et al. Cardiopulmonary exercise testing following allogeneic lung transplantation for different underlying disease states. Chest 107 1 (1995) 144-149
84. Schwaiblmair M., Reichenspurner H., Muller C., et al. Cardiopulmonary exercise testing before and after lung and heart-lung transplantation. Am J Respir Crit Care Med 159 4 Pt 1 (1999) 1277-1283
85. Theodore J., Morris A.J., Burke C.M., et al. Cardiopulmonary function at maximum tolerable constant work rate exercise following human heart-lung transplantation. Chest 92 3 (1987) 433-439
86. Oelberg D.A., Systrom D.M., Markowitz D.H., et al. Exercise performance in cystic fibrosis before and after bilateral lung transplantation. J Heart Lung Transplant 17 11 (1998) 1104-1112
87. Levy R.D., Ernst P., Levine S.M., et al. Exercise performance after lung transplantation. J Heart Lung Transplant 12 1 Pt 1 (1993) 27-33
88. McKenna M.J., Fraser S.F., Li J.L., et al. Impaired muscle Ca2+ and K+ regulation contribute to poor exercise performance post-lung transplantation. J Appl Physiol 95 4 (2003) 1606-1616
89. Tirdel G.B., Girgis R., Fishman R.S., et al. Metabolic myopathy as a cause of the exercise limitation in lung transplant recipients. J Heart Lung Transplant 17 12 (1998) 1231-1237
90. Mercier J.G., Hokanson J.F., and Brooks G.A. Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in rats. Am J Respir Crit Care Med 151 5 (1995) 1532-1536
91. Evans A.B., Al-Himyary A.J., Hrovat M.I., et al. Abnormal skeletal muscle oxidative capacity after lung transplantation by 31P-MRS. Am J Respir Crit Care Med 155 2 (1997) 615-621
92. TenVergert E.M., Essink-Bot M.L., Geertsma A., et al. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest 113 2 (1998) 358-364
93. MacNaughton K.L., Rodrigue J.R., Cicale M., et al. Health-related quality of life and symptom frequency before and after lung transplantation. Clin Transpl 12 4 (1998) 320-323
94. Vermeulen K.M., Ouwens J.P., van der Bij W., et al. Long-term quality of life in patients surviving at least 55 months after lung transplantation. Gen Hosp Psychiatry 25 2 (2003) 95-102
95. Lanuza D.M., Lefaiver C., McCabe M., et al. Prospective study of functional status and quality of life before and after lung transplantation. Chest 118 1 (2000) 115-122
96. de Perrot M., Liu M., Waddell T.K., et al. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167 4 (2003) 490-511
97. Christie J.D., Carby M., Bag R., et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24 10 (2005) 1454-1459
98. Christie J.D., Van Raemdonck D., de Perrot M., et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods. J Heart Lung Transplant 24 10 (2005) 1451-1453
99. Christie J.D., Kotloff R.M., Pochettino A., et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 124 4 (2003) 1232-1241
100. Thabut G., Mal H., Cerrina J., et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. Am J Respir Crit Care Med 171 7 (2005) 786-791
101. Christie J.D. Lung allograft ischemic time: crossing the threshold. Am J Respir Crit Care Med 171 7 (2005) 673-674
102. Christie J.D., Bavaria J.E., Palevsky H.I., et al. Primary graft failure following lung transplantation. Chest 114 1 (1998) 51-60
103. Christie J.D., Sager J.S., Kimmel S.E., et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 127 1 (2005) 161-165
104. Mughal M.M., Gildea T.R., Murthy S., et al. Short-term deployment of self-expanding metallic stents facilitates healing of bronchial dehiscence. Am J Respir Crit Care Med 172 6 (2005) 768-771
105. Schmid R.A., Boehler A., Speich R., et al. Bronchial anastomotic complications following lung transplantation: still a major cause of morbidity?. Eur Respir J 10 12 (1997) 2872-2875
106. Schroder C., Scholl F., Daon E., et al. A modified bronchial anastomosis technique for lung transplantation. Ann Thorac Surg 75 6 (2003) 1697-1704
107. Barman S.A., Ardell J.L., Parker J.C., et al. Pulmonary and systemic blood flow contributions to upper airways in canine lung. Am J Physiol 255 5 Pt 2 (1988) H1130-H1135
108. Herrera J.M., McNeil K.D., Higgins R.S., et al. Airway complications after lung transplantation: treatment and long-term outcome. Ann Thorac Surg 71 3 (2001) 989-993 [discussion: 993-4]
109. Seymour C.W., Krimsky W.S., Sager J., et al. Transbronchial needle injection: a systematic review of a new diagnostic and therapeutic paradigm. Respiration 73 1 (2006) 78-89
110. Chhajed P.N., Malouf M.A., Tamm M., et al. Interventional bronchoscopy for the management of airway complications following lung transplantation. Chest 120 6 (2001) 1894-1899
111. Chhajed P.N., Malouf M.A., Tamm M., et al. Ultraflex stents for the management of airway complications in lung transplant recipients. Respirology 8 1 (2003) 59-64
112. Hopkins P.M., Aboyoun C.L., Chhajed P.N., et al. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant 21 10 (2002) 1062-1067
113. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 15 1 Pt 1 (1996) 1-15
114. Whelan T.P., and Hertz M.I. Allograft rejection after lung transplantation. Clin Chest Med 26 4 (2005) 599-612 vi
115. Bando K., Paradis I.L., Similo S., et al. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 110 1 (1995) 4-13 [discussion: 13-4]
116. Boehler A., and Estenne M. Obliterative bronchiolitis after lung transplantation. Curr Opin Pulm Med 6 2 (2000) 133-139
117. Sundaresan S., Trulock E.P., Mohanakumar T., et al. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg 60 5 (1995) 1341-1346 [discussion: 1346-7]
118. Kroshus T.J., Kshettry V.R., Savik K., et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 114 2 (1997) 195-202
119. Nicod L.P. Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc 3 5 (2006) 444-449
120. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 3 (2002) 297-310
121. Bankier A.A., Van Muylem A., Knoop C., et al. Bronchiolitis obliterans syndrome in heart-lung transplant recipients: diagnosis with expiratory CT. Radiology 218 2 (2001) 533-539
122. Lee E.S., Gotway M.B., Reddy G.P., et al. Early bronchiolitis obliterans following lung transplantation: accuracy of expiratory thin-section CT for diagnosis. Radiology 216 2 (2000) 472-477
123. Leung A.N., Fisher K., Valentine V., et al. Bronchiolitis obliterans after lung transplantation: detection using expiratory HRCT. Chest 113 2 (1998) 365-370
124. Gerhardt S.G., McDyer J.F., Girgis R.E., et al. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 168 1 (2003) 121-125
125. Yates B., Murphy D.M., Forrest I.A., et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 172 6 (2005) 772-775
126. Kotloff R.M., and Ahya V.N. Medical complications of lung transplantation. Eur Respir J 23 2 (2004) 334-342
127. Weill D., Dey G.C., Hicks R.A., et al. A positive donor gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant 21 5 (2002) 555-558
128. Horvath J., Dummer S., Loyd J., et al. Infection in the transplanted and native lung after single lung transplantation. Chest 104 3 (1993) 681-685
129. Kramer M.R., Marshall S.E., Starnes V.A., et al. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Intern Med 153 17 (1993) 2010-2016
130. Maurer J.R., Tullis D.E., Grossman R.F., et al. Infectious complications following isolated lung transplantation. Chest 101 4 (1992) 1056-1059
131. Gasink L.B., and Blumberg E.A. Bacterial and mycobacterial pneumonia in transplant recipients. Clin Chest Med 26 4 (2005) 647-659 vii
132. Boehler A., and Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 22 6 (2003) 1007-1018
133. Zamora M.R. Cytomegalovirus and lung transplantation. Am J Transplant 4 8 (2004) 1219-1226
134. Khalifah A.P., Hachem R.R., Chakinala M.M., et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 170 2 (2004) 181-187
135. Mehrad B., Paciocco G., Martinez F.J., et al. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 119 1 (2001) 169-175
136. Birsan T., Taghavi S., and Klepetko W. Treatment of aspergillus-related ulcerative tracheobronchitis in lung transplant recipients. J Heart Lung Transplant 17 4 (1998) 437-438
137. Cahill B.C., Hibbs J.R., Savik K., et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 112 5 (1997) 1160-1164
138. Kessler R., Massard G., Warter A., et al. Bronchial-pulmonary artery fistula after unilateral lung transplantation: a case report. J Heart Lung Transplant 16 6 (1997) 674-677
139. Levine S.M., Angel L., Anzueto A., et al. A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients. Chest 116 5 (1999) 1273-1277
140. Reams B.D., McAdams H.P., Howell D.N., et al. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Chest 124 4 (2003) 1242-1249
141. Loren A.W., Porter D.L., Stadtmauer E.A., et al. Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant 31 3 (2003) 145-155
142. Kotloff R.M., and Ahya V.N. Pulmonary considerations in organ and hematopoietic stem cell transplantation. Clin Chest Med 26 4 (2005) 517-739